sykdomsmodifisering
Sykdomsmodifisering, also known as disease modification, refers to the alteration of the underlying progression of a disease, rather than merely treating its symptoms. This approach aims to slow down, halt, or even reverse the progression of a disease, potentially leading to improved long-term outcomes for patients.
In the context of chronic diseases, such as multiple sclerosis, Alzheimer's, or certain types of cancer, sykdomsmodifisering
For example, in multiple sclerosis, disease-modifying drugs aim to reduce the frequency and severity of relapses
The development of disease-modifying treatments often involves a deep understanding of the disease's pathophysiology and the
However, challenges remain, including the need for early diagnosis to intervene before significant damage occurs, as